Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...

Additional details are included in, and the description above is qualified in its entirety by, AIM’s Current Report on Form 8-K filed with the SEC on April 4, 2025, which will be made available under ...

Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: Good day, everyone, and welcome to the Vivos Therapeutics Full Year ...

Coya Therapeutics, Inc. (COYA) closed the last trading session at $6.51, gaining 8.5% over the past four weeks, but there ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Lupin Digital Health has launched a Post-Procedure Home-Based Care Guide, developed alongside the American College of ...

Please see the full Prescribing Information, including Medication Guide. About Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...

March 26, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq ... and fellow board members to help guide the Company’s future growth and strategic direction.” Michael Heffernan is a seasoned ...